期刊文献+

RANTES及趋化因子受体CCR5在特应性皮炎皮损中的表达及其意义 被引量:7

Expression of RANTES and Chemokine Receptors CCR5 in Patients with Atopic Dermatitis and Its Significance
下载PDF
导出
摘要 目的探讨调节正常T细胞表达和分泌活性因子(regulated on activation normal Tcell expressed and secreted,RANTES)及趋化因子受体CCR5在特应性皮炎皮损的表达及其意义。方法采用荧光定量聚合酶链反应法测定20例特应性皮炎患者皮损内及16例正常对照者皮肤内RANTESmRNA及CCR5mRNA的定量表达,采用SCORAD评分评估患者病情,分析特应性皮炎患者皮损内RANTESmRNA及CCR5mRNA的定量表达与SCORAD评分相关性。结果特应性皮炎患者皮损内RANTESmRNA及CCR5mRNA的表达明显高于正常对照组皮肤内的表达(t=10.2,P<0.001;t=2.32,P=0.0318);特应性皮炎患者皮损内RANTESmRNA及CCR5mRNA的定量表达与SCORAD评分均呈显著的正相关(r=0.78465,P<0.0001;r=0.72465,P=0.0003),RANTESmRNA与CCR5mRNA的定量表达呈显著的正相关(r=0.64838,P=0.0020)。结论皮损内RANTES及CCR5的过度表达可能在特应性皮炎的发病中起一定作用。 Objective To investigate the significance and expression of regulated on activation normal T cell expressed and secreted(RANTES) and chemokine receptors CCR5 in patients with atopic dermatitis(AD). Methods 20 adult patients with AD and 16 health controls were sequentially enrolled in this study. The production of RANTES mRNA and CCR5 mRNA was measured by fluorescent quantitative polymerase chain reaction. The patients's condition was measured by SCORAD. The correlation between expression of RANTES mRNA and CCR5 mRNA and SCORAD was analyzed. Results Expression of RANTES mRNA and CCR5 mRNA in AD was significantly higher than that in health controls (t=10.2, P〈0.001; t=2.32, P= 0.0318). Significant posivtive correlation in AD was found between expression of RANTES mRNA and CCR5 mRNA and SCORAD scores (r=0.78465, P〈0.0001; r=0.72465, P=0.0003). Significant positive correlation in AD was found between expression of RANTES mRNA and CCR5 mRNA (r=0.64838, P=0.0020).Conclusion Our results suggest possible role of RANTES and CCR5 in the development of AD.
出处 《中国中西医结合皮肤性病学杂志》 CAS 2010年第3期146-148,共3页 Chinese Journal of Dermatovenereology of Integrated Traditional and Western Medicine
关键词 特应性皮炎 调节正常T细胞表达和分泌活性因子 趋化因子受体 CCR5 atopic dermatitis regulated on activation normal T cell expressed and secreted chemokine receptors CCR5
  • 相关文献

参考文献11

  • 1Oyoshi MK,He R,Kumar L,et al.Cellular and molecular mechanisms in atopic dermatitis[J].Adv Immunol,2009,102:135-226.
  • 2吴江,曾仁山.异位性皮炎患者外周血Th2细胞分化偏态性分析[J].中国麻风皮肤病杂志,2005,21(8):616-617. 被引量:6
  • 3Hanifin JM.Chan S.Biochemical and immunologic mechanisms in atopic dermatitis:new targets for emerging therapies[J].J Am Acad Dermalol,1999.41:72-77.
  • 4Leung DY.Atopic dermatitis:new insights and opportunities for therapeutic intervention[J].J Allergy Clin Immunol,2000,105:860-876.
  • 5Kato Y,Pawunkar R,Kimura Y,et al.Increased expression of RANTES.CCR3 and CCR5 in the lesional skin of patients with atopic eczema[J].Int Arch Allergy Immunol,2006,139:245-257.
  • 6Hanifin JM.Rajka G.Diagnostic features of atopic dermatitis[J].Arch Dermatol Venerol (Stockh),1980,92:44-47.
  • 7Kunz B,Oranje AP,Labreze L,et al.Clinical validation and guidelines for the SCOKAD index:consensus report of the European Task Force on Atopic Dermalitis[J].Dermatol.l997,195:10-19.
  • 8Bonecchi R,Galliera E,Borroni EM.et al.Chemokines and chemokine receptors:an overview[J].Front Biosci,2009,14:540-551.
  • 9Zlotnik A,Yoshie O.Chemokines:a new classification system and their role in immunity[J].Immunity,2000,12:121-7.
  • 10Viola A,Molon B,Contento RL.Chemokines:coded messages for Tcell missions[J].Front Biosci.2008,13:6341-6353.

二级参考文献16

  • 1陈绍平,刘力兴,陈小兵,张国元.哮喘患者痰液巨噬细胞炎症蛋白1α含量变化及意义[J].川北医学院学报,2005,20(1):10-13. 被引量:3
  • 2Hanifin JM, Chan S. Biochemical and inununologic mechanisms in atopic dermatitis: new targets for emerging therapies. J Am Acad Dennatol 1999 ; 41 : 72 - 77.
  • 3Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000; 105: 860-876.
  • 4Mosman TR, Sad S. The expanding universe of T cell subsets:Th1,Th2 and more. Immunol Today 1996; 17:138 - 146.
  • 5Tanaka K, Kemmotsu K, Ogawa K, et al. Flow cylometric analysis of helper T cell subsets (Thl and Th2) in healthy adults. Rinsho Byori 1998;46:1247 - 1251.
  • 6Barata LT, Ying S, Meng Q, et al. 1L - 4 and IL - 5 - positive T lymphocyles, eosinophils, and mast cells in allergen- induced late phase cutaneous reactions in atopic subjiecs. J Allergy Clin Immunol 1998; 101:222 - 230.
  • 7Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity, Immunity 2000; 12:121 - 127.
  • 8Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (This) and Th2s.J Exp Med 1998; 187:129 - 134.
  • 9Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997;277:2005 - 2007.
  • 10Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4- beating Th2 cells toward antigen - presenting ceils by the CC chemokines thymus and activation- regulated chemokine and macrophage- derived chemokine. Int Immunol 1999; 11:81 - 88.

共引文献6

同被引文献66

  • 1张慧,杨森,张学军.特应性皮炎易感基因研究进展[J].国际遗传学杂志,2006,29(6):472-475. 被引量:3
  • 2Oyoshi MK,He R,Kumar L,et al.Cellular and molecular mechanisms in atopic dermatitis[J].Adv Immunol,2009,102:135-226.
  • 3Hanifin JM,Rajka G.Diagnositic features of atopic dermatitis[J].Arch Dermatol Venerol,1980,92:44-47.
  • 4Hanifin JM,Thurston M,Omoto M,et al.The eczema area and severity index (EASI):assessment of reliability in atopic dermatitis[J].EASI Evaluator Group.Exp Dermatol,2001,10(1):11-18.
  • 5Lutfalla G,Uze G.Performing quantitative reverse-transcribed polymerase chain reaction experiments[J].Methods Enzymol,2006,410:386-400.
  • 6Marini M,Vittori E,Hollembog J,et a1.Expression of the potent inflammatory cytokines,granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8,in bronchial epithelial cells of patients with asthma[J].J Allergy Clin Immunol,1992,89(5):1001-1009.
  • 7Zingoni A,Chensue SW,Lukacs NW,et al.Aberrant in vivo T helpertype2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice[J].J exp Med,2001,193(5):573-584.
  • 8Schultz I.arsen F, Hanfin J. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am, 2002,22: 1 24.
  • 9Enomoto H, Hirata K, Otsuka K, et al. Filaggrin null mutations are associated with atopic dermatitis and elevated levels of IgE in the Japanese population: a family and casecontrol study. J HumGenet, 2008, 53:615 -621.
  • 10Ma L, Zhang L, Di ZH, et al. Association analysis of filaggrin gene mutations and atopic dermatitis in northern China. Br J Dermatol, 2010,162 : 225-227.

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部